Intersect ENT, Inc.
Intersect ENT, Inc. lists 1 drug product in the FDA National Drug Code directory.
Products
Recalls by Intersect ENT, Inc.
- D-0167-2023 Jan 25, 2023 · Class III
Failed Dissolution Specification; product did not meet the average 24-hour drug release rate (dissolution) specification stability time point at 9 months.